Top Markets
Coin of the day
AlzeCure Pharma AB AlzeCure Pharma AB

AlzeCure Pharma AB

ALZCUR
Pozycja w akcjach #22112
AlzeCure Pharma AB (publ) operates as a pharmaceutical company that develops... AlzeCure Pharma AB (publ) operates as a pharmaceutical company that develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system. The company is involved in the development of drug candidates based on the NeuroRestore, Alzstatin, and Painless research platforms. Its products pipeline includes ACD856 for the treatment of Alzheimer’s disease, sleep disorders, depression, traumatic brain injuries, and Parkinson’s disease, which is in phase I clinical trial; ACD857, ACD679, and ACD680 that are in preclinical trial for the treatment of Alzheimer’s disease; ACD440, a TRPV1 antagonist that has completed phase I clinical trial for neuropathic pain indications; and ACD137, negative allosteric modulator (NAM) of TrkA receptors for osteoarthritic pain indications. The company was founded in 2012 and is based in Huddinge, Sweden.
Cena akcji
$0.71707249
Ostatnia synchronizacja: 2026-08-21
Kapitalizacja rynkowa
$94.14M
Zmiana (1 dzień)
-3.31%
Zmiana (1 rok)
76.82%
Kraj
SE
Handel AlzeCure Pharma AB (ALZCUR)

Kategoria

Historia ceny akcji dla AlzeCure Pharma AB (ALZCUR)
Najwyższa cena zamknięcia: $0.75 dnia 2026-08-01

Najniższa cena zamknięcia: $1.08 dnia 2018-11-01
Historia cen akcji firmy AlzeCure Pharma AB od 2018 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 27.37%
2025 118.89%
2024 -63.25%
2023 -21.67%
2022 -38.07%
2021 -40.60%
2020 149.60%
2019 -53.66%
2018 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH